Article
New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.
Endocrinology - 1 Feb 2022
Pérez Piñero Cecilia, Giulianelli Sebastián, Lamb Caroline A, Lanari Claudia
Abstract excerpt
Luminal breast cancer (BrCa) has a favorable prognosis compared with other tumor subtypes. However, with time, tumors may evolve and lead to disease progression; thus, there is a great interest in unraveling the mechanisms that drive tumor metastasis and endocrine resistance. In this review, we focus on one of the many pathways that have been involved in tumor progression, the fibroblast growth factor/fibroblast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
